Additional behavioral performance metrics before and after viral injection and electrophysiological validation of CRISPR-SaCas9 mediated deletion of Slc17a6 (vGlut2) on GABA/glutamate cotransmission from EPSst+ neurons.
(A) Trial duration (normalized to mean before AAV injection (day-5-day-1), red dashed line) across behavioral sessions (days) before and after AAV injection of sgROSA26 (black) or sgSlc17a6 (gray) (n=10 sgROSA26, n=8 sgSlc17a6 animals, dots = mean, error bar = SEM). (B) p(high port) (normalized to mean before AAV injection (day-5-day-1), red dashed line) across behavioral sessions (days) before and after AAV injection of sgROSA26 (black) or sgSlc17a6 (gray) (n=10 sgROSA26, n=8 sgSlc17a6 animals, dots = mean, error bar = SEM). (C) p(switch) (normalized to mean before AAV injection (day-5-day-1), red dashed line) across behavioral sessions (days) before and after AAV injection of sgROSA26 (black) or sgSlc17a6 (gray) (n=10 sgROSA26, 8 sgSlc17a6 animals, dots = mean, error bar = SEM). (D-I) Behavioral metrics for sgROSA26 (blue) and sgSlc17a6 (orange) injected animals before (gray) and after (color) injection of AAV (dots = individual mice, bar = mean, error bars = 95% CI) (E; ROSA26 paired t-test, DF=9, p-value=0.002, Slc17a6 paired t-test, DF=7, p-value=0.004, F; ROSA26 paired t-test, DF=9, p-value=0.05, I; ROSA26 paired t-test, DF=9, p-value=0.03). (J) Sample whole-cell voltage-clamp recordings from lateral habenula (LHb) neurons clamped at either 0 mV (gray) or −65 mV (black) to isolate optogenetically evoked IPSCs or EPSCs, respectively, from oChief+ EPSst+ axons. Sample traces on top are from a Sst-Cre+ animal expressing both oChief and sgROSA26 in EP and bottom traces are from a Sst-Cre+ animal expressing both oChief and sgSlc17a6 blue dashes represent the timing of the blue light pulse (1 ms duration). (K) Quantification of peak amplitude from optogenetically evoked IPSCs (top) and EPSCs (bottom) from sgROSA26 (control, left) and sgSlc17a6 (right) groups (n=13 cells control, n=23 cells Tettx; bar = mean, error bar = SEM) (top; Mann W. DF=60, p=0.0025, bottom; Mann W. DF=46, p=0.0004). (L) p(switch) for trial types divided by reward history and choice direction segregated into before injection (gray) and after injection (blue=sgROSA26, left; orange=sgSlc17a6, right) (bar = mean, error bar = 95% CI). (M) Summary of RFLR model coefficients segregated into before injection (gray) and after injection (blue=sgROSA26; orange=sgSlc17a6), each dot represents an individual mouse (bar = mean, error bar = SEM, negative log-likelihood of fits were equivalent across conditions; ROSA26= −0.25 SD=0.05; Slc17a6= −0.24 SD=0.05). (N) Trial duration following previously rewarded or unrewarded trials segregated into before injection (gray) and after injection (blue=sgROSA26; orange=sgSlc17a6) (bar = mean, error bar = 95% CI). A-I and L-N n=10 sgROSA26 control and n=8 sgSlc17a6 mice, 5 sessions/mouse before AAV inj. and 10 session/mouse after AAV injection, sgROSA26 control= 17,318 trials before, 39,710 trials after; sgSlc17a6 = 13,520 trials before, 29,256 trials after.